Key points are not available for this paper at this time.
To evaluate the clinical features and pregnancy outcomes in patients experiencing recurrent miscarriage (RM) with either low-titer or medium-high titer positivity of antiphospholipid antibodies (aPL).
Chen et al. (2024) studied this question.